AtriCure to Present at the UBS Global Healthcare Conference
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage
management, today announced that it will present at the UBS Global Healthcare Conference at the Grand Hyatt in New York on Monday,
May 23, 2016. Management is scheduled to present at 11:00 a.m. Eastern Time. A live audio webcast of the presentation may be
accessed by visiting the Investors page of AtriCure’s corporate website at www.atricure.com. A replay of the presentation will be available for 90 days following the presentation.
About AtriCure, Inc.
AtriCure, Inc. is a medical device company providing innovative atrial fibrillation (Afib) solutions designed to produce
superior outcomes that reduce the economic and social burden of atrial fibrillation. AtriCure’s Synergy™ Ablation System is the
first and only surgical device approved for the treatment of persistent and longstanding persistent forms of Afib in patients
undergoing certain open concomitant procedures. AtriCure’s AtriClip left atrial appendage management (LAAM) exclusion device is the
most widely sold device worldwide that is indicated for the occlusion of the left atrial appendage. The company believes
cardiothoracic surgeons are adopting its ablation and LAAM devices for the treatment of Afib and reduction of Afib related
complications such as stroke. AtriCure recently acquired nContact, a leader in minimally invasive technology for epicardial
ablation. nContact’s mission is to transform the underserved arrhythmia population through a multidisciplinary
epicardial-endocardial ablation approach. Afib affects more than 33 million people worldwide. For more information visit AtriCure.com or follow us on Twitter @AtriCure.
AtriCure, Inc.
Andy Wade
Senior Vice President and Chief Financial Officer
513-755-4564
awade@atricure.com
or
Investor Relations
Gilmartin Group
Lynn Pieper
415-937-5402
lynn@gilmartinir.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160502006040/en/